Chronic Rhinosinusitis With Nasal Polyps Clinical Trials
2 recruiting trials for Chronic Rhinosinusitis With Nasal Polyps. Eligibility criteria explained in plain English.
TrialFinderData lists 2 Chronic Rhinosinusitis With Nasal Polyps clinical trials drawn from ClinicalTrials.gov, all of which are currently recruiting participants.
Research is led by University Hospital, Ghent (1), Aristotle University Of Thessaloniki (1), among the most active sponsors registered for these trials.
The most frequently studied intervention is Mepolizumab (biological, 1 trial), followed by Mepolizumab 100 MG [Nucala].
Track Chronic Rhinosinusitis With Nasal Polyps trials
Subscribe for TrialFinderData updates by email. No spam, unsubscribe anytime.
Recruiting Trials
Clinical trial data sourced from the ClinicalTrials.gov registry, maintained by the National Library of Medicine. Always consult your doctor before considering any clinical trial.
Real Life Study of Biologicals in Patients With Severe CRSwNP
This study is a pragmatic, real-life, observational study recruiting adult patients with chronic rhinosinusitis with nasal polyposis who are eligible to start biologicals as...
Biomarkers of Response to Mepolizumab Treatment in Patients With Nasal Polyps With or Without Bronchial Asthma
Mepolizumab is a biologic agent already approved for severe asthma. Recently, there is increasing evidence concerning the benefit of anti-IL5 treatments upon patients with nasal...
Explore Other Conditions
Frequently Asked Questions
There are currently 2 clinical trials for Chronic Rhinosinusitis With Nasal Polyps, with 2 actively recruiting participants. These include trials across all phases from early-stage Phase 1 to late-stage Phase 3.
To join a clinical trial for Chronic Rhinosinusitis With Nasal Polyps, review the eligibility criteria on the trial detail pages, then talk to your doctor about whether a trial is right for you. Your doctor can help you evaluate the potential benefits and risks.
Phase 3 trials are large-scale studies that test whether a treatment is effective and monitor side effects. There are 0 Phase 3 trials for Chronic Rhinosinusitis With Nasal Polyps, representing treatments closest to potential FDA approval.
Clinical trials follow strict safety protocols overseen by Institutional Review Boards (IRBs) and the FDA. Participants are monitored closely and can withdraw at any time. Always discuss risks and benefits with your healthcare provider before enrolling.
Trial data sourced from the ClinicalTrials.gov API. This site does not provide medical advice, always talk to your doctor about clinical trial participation.